摘要:
Structural modifications of CGS 26303, a non-peptidic alpha-aminophosphonate dual ECE/NEP inhibitor lead, were performed to maximize inhibition of recombinant human ECE-1, while maintaining strong NEP inhibition. Specifically, substitution of the a-aminophosphonate moiety with aryl ethyl sidechains led to the discovery of a new class of potent, non-peptidic, dual inhibitors, such as CGS 31447, which blocked ECE-1 and NEP activities with IC50's of 17 and 5 nM, respectively. (C) 1997 Elsevier Science Ltd.